To validate the FRAIL scale.
Representative sample of African Americans age 49 to 65 years at onset of study.
The 5-item FRAIL scale (Fatigue, Resistance, Ambulation, Illnesses, & Loss of Weight), at baseline and activities of daily living (ADLs), instrumental activities of daily living (IADLs), mortality, short physical performance battery (SPPB), gait speed, one-leg stand, grip strength and injurious falls at baseline and 9 years. Blood tests for CRP, SIL6R, STNFR1, STNFR2 and 25 (OH) vitamin D at baseline.
Cross-sectionally the FRAIL scale correlated significantly with IADL difficulties, SPPB, grip strength and one-leg stand among participants with no baseline ADL difficulties (N=703) and those outcomes plus gait speed in those with no baseline ADL dependencies (N=883). TNFR1 was increased in pre-frail and frail subjects and CRP in some subgroups. Longitudinally (N=423 with no baseline ADL difficulties or N=528 with no baseline ADL dependencies), and adjusted for the baseline value for each outcome, being pre-frail at baseline significantly predicted future ADL difficulties, worse one-leg stand scores, and mortality in both groups, plus IADL difficulties in the dependence-excluded group. Being frail at baseline significantly predicted future ADL difficulties, IADL difficulties, and mortality in both groups, plus worse SPPB in the dependence-excluded group.
This study has validated the FRAIL scale in a late middle-aged African American population. This simple 5-question scale is an excellent screening test for clinicians to identify frail persons at risk of developing disability as well as decline in health functioning and mortality.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Morley JE, Perry HM III, Miller DK. Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci 2002;57:M698–M704.
Fried LP, Ferrucci L, Darer J, et al. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004;59:255–263.
Morley JE. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009;15:3384–3395.
Theou O, Stathokostas L, Roland KP, et al. The effectiveness of exercise interventions for the management of frailty: a systematic review. J Aging Res 2011;56:91–94.
Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia. J Am Med Dir Assoc 2010;11:391–396.
Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639–650.
Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–M156.
Ensrud KE, Ewing SK, Taylor BC, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008;168:382–389.
Abellan van Kan G, Rolland Y, Bergman H, et al. The I.A.N.A. Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008;12:29–37.
Abellan van Kan G, Rolland YM, Morley JE, Vellas B. Frailty: toward a clinical definition. J Am Med Dir Assoc 2008;9:71–72.
Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001;56:M158–M166.
Rockwood K, Hogan DB, MacKnight C. Conceptualisation and measurement of frailty in elderly people. Drugs Aging 2000;17:295–302.
Hirsch C, Anderson ML, Newman A, et al. The association of race with frailty: The Cardiovascular Health Study. Ann Epidemiol 2006;16:545–553.
Mendes de Leon CF, Barnes LL, Bienias JL, et al. Racial disparities in disability: recent evidence from self-reported and performance-based disability measures in a populationbased study of older adults. J Gerontol B Psychol Sci Soc Sci 2005;60:S263–S271.
Miller DK, Wolinsky FD, Malmstrom TK, et al. Inner city, middle-aged African Americans have excess frank and subclinical disability. J Gerontol A Biol Sci Med Sci 2005;60:207–212.
Miller DK, Malmstrom TK, Joshi S, et al. Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans. J Am Geriatr Soc 2004;52:741–748.
Wolinsky FD, Miller DK, Andresen EM, et al. Health-related quality of life in middleaged African Americans. J Gerontol B Psychol Sci Soc Sci 2004;59:S118–S123.
National Center for Health Statistics. Data File Documentation, National Health Interview Second Supplement on Aging, 1994 (machine readable data file and documentation). Hyattsville, MD: National Center for Health Statistics, 1998.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186.
Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85–M94.
Volpato S, Cavalieri M, Sioulis F, et al. Predictive value of the short physical performance battery following hospitalization in older patients. J Gerontol A Biol Sci Med Sci 2011;66:89–96.
Miller DK, Wolinsky FD, Andresen EM, et al. Adverse outcomes and correlates of change in the Short Physical Performance Battery over 36 months in the African American Health project. J Gerontol A Biol Sci Med Sci 2008;63:487–494.
Miller DK, Malmstrom TK, Miller JP, et al. Predictors of change in grip strength over 3 years in the African American Health project. J Aging Health 2010;22:183–196.
Andresen EM, Wolinsky FD, Miller JP et al. Cross-sectional and longitudinal risk factors for falls, fear of falling, and the falls efficacy in a cohort of middle-aged African Americans. Gerontologist 2006;46(2):249–257.
Haren MT, Malmstrom TK, Miller DK, et al. Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: A cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 2010;65:274–281.
Hyde Z, Flicker L, Almeida OP, et al. Low free testosterone predicts frailty in older men: The Health in Men Study. J Clin Endocrniol Metab 2010;3165-3172.
Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005:173;489–495.
Liu CK, Fielding RA. Exercise as an intervention for frailty. Clin Geriatr Med 2011;27:101–110.
Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010;363:109–122.
Leng SX, Xue QL, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007;55:864–871.
Spate U, Schulze PC. Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7:265–269.
Ferrucci L, Harris TB, Guralnik JM, et al. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc 1999;47:639–646.
Rolland Y, Czerwinski S, Abellan van Kan G, et al. Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging 2008;12:433–450.
Morley JE. Vitamin D redux. J Am Med Dir Assoc 2009;10:591–592.
Shardell M, Hicks GE, Miller RR, et al. Association of low vitamin D levels with the frailty syndrome in men and women. J Gerontol A Biol Sci Med Sci 2009;64:69–75.
Ensrud KE, Blackwell TL, Cauley JA, et al. Circulating 25-hydroxyvitamin D levels and frailty in older men: the osteoporotic fractures in men study. J Am Geriatr Soc 2011;59:101–106.
About this article
Cite this article
Morley, J.E., Malmstrom, T.K. & Miller, D.K. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 16, 601–608 (2012). https://doi.org/10.1007/s12603-012-0084-2
- African Americans
- physical performance